Signaling networks in the pathophysiology and treatment of mood disorders

被引:87
作者
Gould, TD [1 ]
Manji, HK [1 ]
机构
[1] NIMH, Mol Pathophysiol Lab, NIH, Bethesda, MD 20892 USA
关键词
adenylate cyclase; bipolar disorder; depression; G proteins; phosphotidylinositol; second messenger systems;
D O I
10.1016/S0022-3999(02)00426-9
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Over the past decade, the focus of research into the pathophysiology of mood disorders (bipolar disorder and unipolar depression in particular) has shifted from an interest in the biogenic amines to an emphasis on second messenger systems within cells. Second messenger systems rely on cell membrane receptors to relay information from the extracellular environment to the interior of the cell. Within the cell, this information is processed and altered, eventually to the point where gene and protein expression patterns are changed. There is a preponderance of evidence implicating second messenger systems and their primary contact with the extracellular environment, G proteins, in the pathophysiology of mood disorders. After an introduction to G proteins and second messenger pathways, this review focuses on the evidence implicating G proteins and two second messenger systems-the adenylate cyclase (cyclic adenosine monophosphate, cAMP) and phosphoinositide (protein kinase C, PKC) intracellular signaling cascades-in the pathophysiologgy and treatment of bipolar disorder and unipolar depression. Emerging evidence implicates changes in cellular resiliency, neuroplasticity and additional cellular pathways in the pathophysiology of mood disorders. The systems discussed within this review have been implicated in neuroplastic processes and in modulation of many other cellular pathways, making them likely candidates for mediators of these findings. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:687 / 697
页数:11
相关论文
共 129 条
[1]   THE MARCKS BROTHERS - A FAMILY OF PROTEIN-KINASE-C SUBSTRATES [J].
ADEREM, A .
CELL, 1992, 71 (05) :713-716
[2]   REDUCED BRAIN INOSITOL IN LITHIUM-TREATED RATS [J].
ALLISON, JH ;
STEWART, MA .
NATURE-NEW BIOLOGY, 1971, 233 (43) :267-&
[3]   LITHIUM INHIBITION OF FORSKOLIN-STIMULATED ADENYLATE-CYCLASE [J].
ANDERSEN, PH ;
GEISLER, A .
NEUROPSYCHOBIOLOGY, 1984, 12 (01) :1-3
[4]  
Avissar S, 1997, AM J PSYCHIAT, V154, P211
[5]   NEURAL AND DEVELOPMENTAL ACTIONS OF LITHIUM - A UNIFYING HYPOTHESIS [J].
BERRIDGE, MJ ;
DOWNES, CP ;
HANLEY, MR .
CELL, 1989, 59 (03) :411-419
[6]   Basic concepts in the study of diseases with complex genetics [J].
Burmeister, M .
BIOLOGICAL PSYCHIATRY, 1999, 45 (05) :522-532
[7]   ALPHA-1 ADRENERGIC-RECEPTOR BINDING AND ADRENERGIC-STIMULATED CYCLIC-AMP PRODUCTION IN RAT CEREBRAL-CORTEX AFTER CHRONIC LITHIUM TREATMENT [J].
CASEBOLT, TL ;
LI, XH ;
JOPE, RS .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1990, 82 (03) :197-204
[8]  
CHARNEY DS, 1982, ARCH GEN PSYCHIAT, V39, P290
[9]  
Chen G, 1998, J NEUROCHEM, V70, P1768
[10]  
Chen G, 1996, NEUROPSYCHOPHARMACOL, V15, P271